ArticleBlood advances2020

Targeting phosphatidylinositol 3 kinase-β and -δ for Bruton tyrosine kinase resistance in diffuse large B-cell lymphoma.

Neeraj Jain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.